DNA Topoisomerases in Cancer Therapy

Present and Future

Nonfiction, Science & Nature, Science, Biological Sciences, Biochemistry, Health & Well Being, Medical, Specialties, Oncology
Cover of the book DNA Topoisomerases in Cancer Therapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461501411
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461501411
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the mid 80's type I and II enzymes were found to be the intracellular targets of a number of efficacious anticancer drugs such as doxorubicin, mitoxantrone, etoposide and camptothecin as a result of a continued efforts of many investigators, especially Leroy Liu and his collaborators at Johns Hopkins University. Readers will find a series of chapters written by researchers actively engaged in the expanding field of topoisomerase and their inhibitors. The series of chapters cover review articles on pharmacology and the molecular mechanism of topoisomerase I- and II-targeting anticancer drugs in mammals and in the yeast Saccharomyces cerevisiae, which has proved to be a superb model organism for studies of anticancer drugs. This volume compiles up-to-date information on the topoisomerase-targeting compounds in clinical and preclinical development as a useful and important reference book for students and researchers in the field of pharmacology, toxicology, oncology and molecular biology.

More books from Springer US

Cover of the book European Socio-Economic Integration by
Cover of the book Tissue Culture of Trees by
Cover of the book Basic and Clinical Aspects of Malignant Melanoma by
Cover of the book Planetary Landscapes by
Cover of the book The Neurology of Neuroblastoma by
Cover of the book Advances in Microbial Control of Insect Pests by
Cover of the book Sustainable Energy Systems and Applications by
Cover of the book Acute Coronary Care 1987 by
Cover of the book Analog Layout Generation for Performance and Manufacturability by
Cover of the book Marine Bioactive Compounds by
Cover of the book The Systematicity Arguments by
Cover of the book Invertebrate Immune Responses by
Cover of the book The Criminal Justice System by
Cover of the book Bacterial Infections of Humans by
Cover of the book Communication by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy